NM_021098.3:c.6013C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_021098.3(CACNA1H):​c.6013C>T​(p.Arg2005Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0595 in 1,547,162 control chromosomes in the GnomAD database, including 3,216 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R2005S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.047 ( 245 hom., cov: 33)
Exomes 𝑓: 0.061 ( 2971 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

5
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.198

Publications

14 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0018978119).
BP6
Variant 16-1219095-C-T is Benign according to our data. Variant chr16-1219095-C-T is described in ClinVar as Benign. ClinVar VariationId is 585654.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0728 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.6013C>T p.Arg2005Cys missense_variant Exon 34 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.6013C>T p.Arg2005Cys missense_variant Exon 34 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000569107.6 linkc.6028C>T p.Arg2010Cys missense_variant Exon 33 of 34 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000711493.1 linkc.5998C>T p.Arg2000Cys missense_variant Exon 33 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.5995C>T p.Arg1999Cys missense_variant Exon 33 of 34 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000711450.1 linkc.5995C>T p.Arg1999Cys missense_variant Exon 34 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.5980C>T p.Arg1994Cys missense_variant Exon 34 of 35 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000638323.1 linkc.5974C>T p.Arg1992Cys missense_variant Exon 34 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000562079.6 linkc.5962C>T p.Arg1988Cys missense_variant Exon 33 of 34 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711438.1 linkc.5956C>T p.Arg1986Cys missense_variant Exon 33 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.6013C>T p.Arg2005Cys missense_variant Exon 34 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.5962C>T p.Arg1988Cys missense_variant Exon 33 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.5935C>T p.Arg1979Cys missense_variant Exon 34 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.6013C>T p.Arg2005Cys missense_variant Exon 34 of 35 ENSP00000518772.1
CACNA1HENST00000621827.2 linkn.6013C>T non_coding_transcript_exon_variant Exon 34 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.*1932C>T non_coding_transcript_exon_variant Exon 33 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.*1061C>T non_coding_transcript_exon_variant Exon 34 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*3831C>T non_coding_transcript_exon_variant Exon 34 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*5457C>T non_coding_transcript_exon_variant Exon 32 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.*954C>T non_coding_transcript_exon_variant Exon 35 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.*872C>T non_coding_transcript_exon_variant Exon 34 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.*1592C>T non_coding_transcript_exon_variant Exon 35 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.*680C>T non_coding_transcript_exon_variant Exon 35 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.*647C>T non_coding_transcript_exon_variant Exon 35 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.5962C>T non_coding_transcript_exon_variant Exon 33 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.6013C>T non_coding_transcript_exon_variant Exon 34 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.5980C>T non_coding_transcript_exon_variant Exon 34 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.*1129C>T non_coding_transcript_exon_variant Exon 34 of 35 ENSP00000518777.1
CACNA1HENST00000637236.3 linkn.*1932C>T 3_prime_UTR_variant Exon 33 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.*1061C>T 3_prime_UTR_variant Exon 34 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*3831C>T 3_prime_UTR_variant Exon 34 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*5457C>T 3_prime_UTR_variant Exon 32 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.*954C>T 3_prime_UTR_variant Exon 35 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.*872C>T 3_prime_UTR_variant Exon 34 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.*1592C>T 3_prime_UTR_variant Exon 35 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.*680C>T 3_prime_UTR_variant Exon 35 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.*647C>T 3_prime_UTR_variant Exon 35 of 36 ENSP00000518765.1
CACNA1HENST00000711488.1 linkn.*1129C>T 3_prime_UTR_variant Exon 34 of 35 ENSP00000518777.1
CACNA1HENST00000711456.1 linkc.5887+444C>T intron_variant Intron 33 of 33 ENSP00000518769.1

Frequencies

GnomAD3 genomes
AF:
0.0470
AC:
7149
AN:
152178
Hom.:
244
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00944
Gnomad AMI
AF:
0.169
Gnomad AMR
AF:
0.0436
Gnomad ASJ
AF:
0.0910
Gnomad EAS
AF:
0.00135
Gnomad SAS
AF:
0.0787
Gnomad FIN
AF:
0.0490
Gnomad MID
AF:
0.0728
Gnomad NFE
AF:
0.0672
Gnomad OTH
AF:
0.0578
GnomAD2 exomes
AF:
0.0566
AC:
8457
AN:
149494
AF XY:
0.0607
show subpopulations
Gnomad AFR exome
AF:
0.00750
Gnomad AMR exome
AF:
0.0330
Gnomad ASJ exome
AF:
0.0954
Gnomad EAS exome
AF:
0.000186
Gnomad FIN exome
AF:
0.0498
Gnomad NFE exome
AF:
0.0664
Gnomad OTH exome
AF:
0.0695
GnomAD4 exome
AF:
0.0609
AC:
84965
AN:
1394866
Hom.:
2971
Cov.:
35
AF XY:
0.0620
AC XY:
42610
AN XY:
687636
show subpopulations
African (AFR)
AF:
0.00831
AC:
262
AN:
31546
American (AMR)
AF:
0.0339
AC:
1205
AN:
35558
Ashkenazi Jewish (ASJ)
AF:
0.0944
AC:
2366
AN:
25066
East Asian (EAS)
AF:
0.000196
AC:
7
AN:
35648
South Asian (SAS)
AF:
0.0851
AC:
6725
AN:
79062
European-Finnish (FIN)
AF:
0.0513
AC:
2424
AN:
47280
Middle Eastern (MID)
AF:
0.0835
AC:
474
AN:
5678
European-Non Finnish (NFE)
AF:
0.0631
AC:
67983
AN:
1077204
Other (OTH)
AF:
0.0609
AC:
3519
AN:
57824
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
3889
7778
11666
15555
19444
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2462
4924
7386
9848
12310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0470
AC:
7151
AN:
152296
Hom.:
245
Cov.:
33
AF XY:
0.0455
AC XY:
3391
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.00941
AC:
391
AN:
41552
American (AMR)
AF:
0.0436
AC:
667
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.0910
AC:
316
AN:
3472
East Asian (EAS)
AF:
0.00135
AC:
7
AN:
5184
South Asian (SAS)
AF:
0.0794
AC:
383
AN:
4824
European-Finnish (FIN)
AF:
0.0490
AC:
520
AN:
10622
Middle Eastern (MID)
AF:
0.0782
AC:
23
AN:
294
European-Non Finnish (NFE)
AF:
0.0672
AC:
4570
AN:
68012
Other (OTH)
AF:
0.0568
AC:
120
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
347
694
1041
1388
1735
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
80
160
240
320
400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0594
Hom.:
323
Bravo
AF:
0.0420
TwinsUK
AF:
0.0618
AC:
229
ALSPAC
AF:
0.0579
AC:
223
ESP6500AA
AF:
0.00739
AC:
25
ESP6500EA
AF:
0.0536
AC:
389
ExAC
AF:
0.0289
AC:
2059
Asia WGS
AF:
0.0310
AC:
108
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jan 07, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 17696120, 28933792, 29588962) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Apr 20, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.090
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Uncertain
-0.080
CADD
Benign
8.9
DANN
Benign
0.93
DEOGEN2
Uncertain
0.51
D;.;.;.
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.18
N
LIST_S2
Benign
0.72
T;T;T;.
MetaRNN
Benign
0.0019
T;T;T;T
MetaSVM
Uncertain
-0.18
T
MutationAssessor
Benign
1.9
L;.;.;.
PhyloP100
0.20
PrimateAI
Benign
0.37
T
PROVEAN
Uncertain
-3.9
D;.;D;D
REVEL
Benign
0.26
Sift
Benign
0.052
T;.;T;T
Sift4G
Uncertain
0.043
D;.;D;D
Polyphen
0.0010
B;.;B;B
Vest4
0.12
ClinPred
0.029
T
GERP RS
-1.9
Varity_R
0.17
gMVP
0.31
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72552056; hg19: chr16-1269095; COSMIC: COSV52359202; COSMIC: COSV52359202; API